Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-37,300
Closed -$183K 80
2016
Q4
$183K Hold
37,300
﹤0.01% 80
2016
Q3
$227K Buy
37,300
+2,100
+6% +$12.6K ﹤0.01% 78
2016
Q2
$208K Hold
35,200
﹤0.01% 73
2016
Q1
$182K Sell
35,200
-1,737,500
-98% -$7.99M ﹤0.01% 73
2015
Q4
$7.91M Buy
1,772,700
+69,300
+4% +$339K 0.17% 59
2015
Q3
$8.35M Buy
1,703,400
+1,356,400
+391% +$7.36M 0.17% 60
2015
Q2
$1.93M Buy
+347,000
New +$2.14M 0.05% 66

Other funds holding ABEV

Sarah Ketterer's ABEV Position: Q1 2017 in Review

Sarah Ketterer sold out of Ambev (ABEV) in Q1 2017, closing a stake of 37,300 shares — an estimated $183K sold.

Sarah Ketterer first reported a position in ABEV in Q2 2015 and held it in 7 quarters. The position peaked at $8.35M in Q3 2015. 294 funds tracked by Wall St. Rank hold ABEV as of Q1 2017.

  • Sarah Ketterer reported no remaining Ambev position as of Q1 2017 after selling out during the quarter.
  • Sarah Ketterer sold 37,300 Ambev shares in Q1 2017, an estimated $183K.
  • Sarah Ketterer first reported a position in Ambev in Q2 2015 and held it in 7 quarters.
  • Sarah Ketterer's Ambev position peaked at $8.35M in Q3 2015.
  • 294 funds tracked by Wall St. Rank held Ambev as of Q1 2017.

Based on Causeway Capital Management's 13F filing for Q1 2017, filed 15 May 2017.